Nav: Home

ENVISAGE and the Wistar Institute forge new venture and value creation partnership

March 10, 2015

PHILADELPHIA--(Mar. 10, 2015)--The Wistar Institute, an international leader in biomedical research, and ENVISAGE L.L.C, a prodigious life sciences venture creation and management firm, are pleased to announce a powerful partnership that leverages Wistar's innovative, high-impact science and ENVISAGE's expertise in managing immunology-infectious disease centered ventures.

"Our unique partnership emanates from pure synergy and collective desire to accelerate the advancement of Wistar's pipeline of value-added, early-stage assets beyond the typical academic technology transfer offering--we are taking active steps to further de-risk our portfolio while ensuring a higher likelihood of success for each and every one of our start-ups founded on Wistar Science," said Heather A. Steinman, Ph.D., M.B.A., The Wistar Institute Vice President for Business Development and Executive Director, Technology Transfer. "We know that our partners will only invest in start-ups with a strong management team in place, and ENVISAGE epitomizes that core capability--that glue. Together, we are the ideal model that can efficiently translate academic discoveries into value-added products that cater to the many unmet patient needs."

Partnering to build successful ventures is the ultimate goal of academia and industry partners alike. The traditional academic venture creation model revolves around identifying a university technology that could become a venture and then finding a management team to advance the venture forward. With this partnership, both ENVISAGE and Wistar aim to streamline this process by combining Wistar's ability to deliver cutting-edge, early-stage assets with ENVISAGE's management expertise (a relationship that is essential to driving early stage ventures towards an inflection point that exceeds both investor and partner expectations).

"We have established a team-driven relationship with Wistar whereby we are not just commercializing, we are becoming operationally involved with each venture," said Vik Subbu, Managing Partner of ENVISAGE L.L.C. "Immunology is our core area of interest and is a strategic fit with Wistar's strength and capabilities. When you combine this vision with Heather's entrepreneurial spirit, you've got a unique public-private model that bridges the translational gap between academic discovery and clinical development."

"As a leading NCI-designated cancer center, our scientific efforts are often focused on finding new solutions for treating cancer," said Dario C. Altieri, M.D., CEO of The Wistar Institute, Director of Wistar's Cancer Center, and the Robert and Penny Fox Distinguished Professor. "We are pleased to be teaming up with ENVISAGE in the immunology-infectious disease space, an important pillar of Wistar Science that we are expanding over the next several years."
-end-
ENVISAGE L.L.C works with a network of key opinion leaders, resident scientists, product development partners, and an experienced board of advisors to advance promising life-sciences innovations into value-add ventures. For more information, visit http://www.envisage-llcs.com.

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. Wistar Science Saves Lives. On the Web at http://www.wistar.org.

The Wistar Institute

Related Biomedical Research Articles:

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.
World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.
Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.
Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.
Fitness tracker data can enhance biomedical research and personalized health
In a research article publishing February 27 in the open access journal PLOS Biology, Weng Khong Lim and colleagues from the SingHealth Duke-NUS Institute of Precision Medicine, Singapore, and the National Heart Centre Singapore show that wearable sensors are not only able to identify groups of volunteers with similar patterns of daily activity, but can also predict various markers of risk for cardiovascular diseases such as obesity, high blood pressure and high blood sugar.
More Biomedical Research News and Biomedical Research Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...